Evidence map›Paper›PMID 27791134›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains.

Anna Müller, Michaela Wenzel, Henrik Strahl, Fabian Grein, Terrens N V Saaki, Bastian Kohl, Tjalling Siersma, Julia E Bandow, Hans-Georg Sahl, Tanja Schneider and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 244 papers.

0numbers the graph read from it
0cells of the map it votes in
244citing papers in PubMed
21.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

244 citing papers in PubMed, 433 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Bacterial cell envelope-targeting antibiotics.Nature reviews. Microbiology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Discovery of Coerumycin, a Cinnamycin-like Lantibiotic fromAntibiotics (Basel, Switzerland) · 2026
    Article
  17. Review
  18. Article
  19. Contribution of theMicrobiology spectrum · 2026
    Article
  20. Article

184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Anna MüllerInstitute of Pharmaceutical Microbiology, University of Bonn, 53115 Bonn, Germany.
Michaela WenzelBacterial Cell Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, 1081 HZ Amsterdam, The Netherlands.
Henrik StrahlCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4AX, United Kingdom.
Fabian GreinInstitute of Pharmaceutical Microbiology, University of Bonn, 53115 Bonn, Germany.
Terrens N V SaakiBacterial Cell Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, 1081 HZ Amsterdam, The Netherlands.
Bastian KohlApplied Microbiology, Ruhr University Bochum, 44801 Bochum, Germany.
Tjalling SiersmaBacterial Cell Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, 1081 HZ Amsterdam, The Netherlands.
Julia E BandowApplied Microbiology, Ruhr University Bochum, 44801 Bochum, Germany.
Hans-Georg SahlGerman Centre for Infection Research, 53127 Bonn, Germany.
Tanja SchneiderInstitute of Pharmaceutical Microbiology, University of Bonn, 53115 Bonn, Germany; l.w.hamoen@uva.nl tanja@mibi03.meb.uni-bonn.de.
Leendert W HamoenBacterial Cell Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, 1081 HZ Amsterdam, The Netherlands; l.w.hamoen@uva.nl tanja@mibi03.meb.uni-bonn.de.
University of Amsterdam · NLGerman Center for Infection Research · DERuhr University Bochum · DENewcastle University · GBUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Daptomycin is a highly efficient last-resort antibiotic that targets the bacterial cell membrane. Despite its clinical importance, the exact mechanism by which daptomycin kills bacteria is not fully understood. Different experiments have led to different models, including (

Indexed as

antibioticsBacillus subtiliscell wall biosynthesisdaptomycinmembrane potential

Identifiers

PMID27791134
PMCPMC5111643
OpenAlexW2537852878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.